Drug Profile
AV 4203
Alternative Names: AV-4203Latest Information Update: 28 Dec 2017
Price :
$50
*
At a glance
- Originator AllaChem
- Class Antivirals; Small molecules
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 28 Dec 2017 No recent reports of development identified for preclinical development in Hepatitis-C in USA
- 12 Nov 2013 Preclinical trials in Hepatitis C in USA (unspecified route)